{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:02:09Z","timestamp":1787022129587,"version":"build-2736575974"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The purpose of this meta-analysis was to assess the safety of the anti-thyroid drugs (ATDs) propylthiouracil (PTU) and methimazole (MMI) in the treatment of hyperthyroidism during pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>From inception until June 2, 2022, all available studies were searched in PubMed, Web of Science, Cochrane, EBSCO, Embase, Scopus, and CNKI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      Thirteen articles satisfying the inclusion criteria were examined. Our meta-analysis indicated that pregnant women treated with MMI had a higher risk of congenital anomalies than those treated with PTU (OR 0.80, 95%CI 0.69\u20130.92,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.002, I\n                      <jats:sup>2<\/jats:sup>\n                      = 41.9%). Shifting between MMI and PTU during pregnancy did not reduce the risk of birth defects compared to PTU alone (OR 1.18, CI 1.00 to 1.40,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.061, I\n                      <jats:sup>2<\/jats:sup>\n                      = 0.0%). There were no statistically significant differences in hepatotoxicity (OR 1.54, 95%CI 0.77\u20133.09,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.221, I\n                      <jats:sup>2<\/jats:sup>\n                      = 0.0%) or miscarriage (OR 0.89, 95%CI 0.72\u20131.11,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.310, I\n                      <jats:sup>2<\/jats:sup>\n                      = 0.0%) between PTU and MMI exposure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study confirmed propylthiouracil is a safer alternative to methimazole for treating hyperthyroidism in pregnant women, and it is appropriate to treat maternal thyroid disease with PTU during the first trimester of pregnancy. However, it is not clear whether switching between propylthiouracil and methimazole is a better option than treating PTU alone during pregnancy. Further studies on this matter may be needed to develop new evidence-based guidelines for the treatment of pregnant women with hyperthyroidism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0286097","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:23:04Z","timestamp":1684502584000},"page":"e0286097","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"18","author":[{"given":"Yue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3383-7281","authenticated-orcid":true,"given":"Yanyan","family":"Men","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"issue":"3","key":"pone.0286097.ref001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ecl.2019.05.002","article-title":"Hyperthyroidism and Pregnancy","volume":"48","author":"K Kobaly","year":"2019","journal-title":"Endocrinology and metabolism clinics of North America"},{"issue":"5","key":"pone.0286097.ref002","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MED.0000000000000492","article-title":"Graves\u2019 hyperthyroidism in pregnancy","volume":"26","author":"CT Nguyen","year":"2019","journal-title":"Current opinion in endocrinology, diabetes, and obesity"},{"issue":"3","key":"pone.0286097.ref003","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3892\/etm.2021.10392","article-title":"Hyperthyroidism management during pregnancy and lactation (Review)","volume":"22","author":"MC Dumitrascu","year":"2021","journal-title":"Exp Ther Med"},{"issue":"6","key":"pone.0286097.ref004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0036-1593489","article-title":"Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period","volume":"34","author":"S Sarkar","year":"2016","journal-title":"Seminars in reproductive medicine"},{"issue":"5","key":"pone.0286097.ref005","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1530\/EJE-18-0678","article-title":"ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later","volume":"179","author":"HB Burch","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"pone.0286097.ref006","doi-asserted-by":"crossref","first-page":"e0265085","DOI":"10.1371\/journal.pone.0265085","article-title":"Efficacy of propylthiouracil in the treatment of pregnancy with hyperthyroidism and its effect on pregnancy outcomes: A meta-analysis","volume":"17","author":"Y Miao","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"pone.0286097.ref007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4158\/EP-2019-0221","article-title":"SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS","volume":"26","author":"W Yu","year":"2020","journal-title":"Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"issue":"7","key":"pone.0286097.ref008","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS medicine"},{"issue":"6","key":"pone.0286097.ref009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000512790","article-title":"2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction","volume":"9","author":"K Poppe","year":"2021","journal-title":"Eur Thyroid J"},{"issue":"4","key":"pone.0286097.ref010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/jcem-65-4-719","article-title":"Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves\u2019 hyperthyroidism","volume":"65","author":"K Okamura","year":"1987","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"pone.0286097.ref011","first-page":"f3676","article-title":"Diagnosis and management of first trimester miscarriage","volume":"346","author":"D Jurkovic","year":"2013","journal-title":"BMJ (Clinical research ed)"},{"issue":"12","key":"pone.0286097.ref012","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1210\/jc.2019-01343","article-title":"Maternal Thyroid Function, Use of Antithyroid Drugs in Early Pregnancy, and Birth Defects","volume":"104","author":"SL Andersen","year":"2019","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"4","key":"pone.0286097.ref013","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/EJE-17-0314","article-title":"Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study","volume":"177","author":"SL Andersen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"pone.0286097.ref014","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"SL Andersen","year":"2013","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"11","key":"pone.0286097.ref015","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1471-0528.2011.03019.x","article-title":"Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study","volume":"118","author":"CH Chen","year":"2011","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"3","key":"pone.0286097.ref016","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1203\/00006450-199509000-00004","article-title":"Premature rats treated with propylthiouracil show enhanced pulmonary antioxidant enzyme gene expression and improved survival during prolonged exposure to hyperoxia","volume":"38","author":"Y Chen","year":"1995","journal-title":"Pediatric research"},{"issue":"6","key":"pone.0286097.ref017","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/thy.2012.0488","article-title":"Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States","volume":"23","author":"JJ Korelitz","year":"2013","journal-title":"Thyroid: official journal of the American Thyroid Association"},{"issue":"6","key":"pone.0286097.ref018","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/thy.2014.0434","article-title":"Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system","volume":"25","author":"JC Lo","year":"2015","journal-title":"Thyroid: official journal of the American Thyroid Association"},{"issue":"6","key":"pone.0286097.ref019","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/M17-1398","article-title":"Antithyroid Drugs and Congenital Malformations: A Nationwide Korean Cohort Study","volume":"168","author":"GH Seo","year":"2018","journal-title":"Annals of internal medicine"},{"issue":"1 Pt 1","key":"pone.0286097.ref020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9378(13)70286-2","article-title":"A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy","volume":"170","author":"DA Wing","year":"1994","journal-title":"American journal of obstetrics and gynecology"},{"issue":"7","key":"pone.0286097.ref021","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of graves\u2019 disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"A Yoshihara","year":"2012","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"6","key":"pone.0286097.ref022","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/nph.17026","article-title":"Kai Zhu","volume":"228","author":"K. Zhu","year":"2020","journal-title":"The New phytologist"},{"issue":"9","key":"pone.0286097.ref023","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40618-015-0281-z","article-title":"Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy","volume":"38","author":"E Gianetti","year":"2015","journal-title":"Journal of endocrinological investigation"},{"issue":"1","key":"pone.0286097.ref024","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/156720181701191226125656","article-title":"Preface","volume":"17","author":"XJ Liang","year":"2020","journal-title":"Current drug delivery"},{"issue":"6","key":"pone.0286097.ref025","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1345\/aph.1H535","article-title":"Propylthiouracil versus methimazole in treatment of Graves\u2019 disease during pregnancy","volume":"41","author":"JM Chattaway","year":"2007","journal-title":"The Annals of pharmacotherapy"},{"issue":"9","key":"pone.0286097.ref026","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"DS Cooper","year":"2005","journal-title":"The New England journal of medicine"},{"issue":"4","key":"pone.0286097.ref027","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association Guideline for the Management of Graves\u2019 Hyperthyroidism","volume":"7","author":"GJ Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"issue":"2","key":"pone.0286097.ref028","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00404-018-5018-8","article-title":"Thyroid function and thyroid disorders during pregnancy: a review and care pathway","volume":"299","author":"AP Delitala","year":"2019","journal-title":"Archives of gynecology and obstetrics"},{"issue":"6","key":"pone.0286097.ref029","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cen.14282","article-title":"Maternal hyperthyroidism and pregnancy outcomes: A population-based cohort study","volume":"93","author":"S Turunen","year":"2020","journal-title":"Clinical endocrinology"},{"issue":"5","key":"pone.0286097.ref030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14740338.2020.1748007","article-title":"Safety of antithyroid drugs in pregnancy: update and therapy implications","volume":"19","author":"T Francis","year":"2020","journal-title":"Expert opinion on drug safety"},{"issue":"7","key":"pone.0286097.ref031","doi-asserted-by":"crossref","first-page":"e0180108","DOI":"10.1371\/journal.pone.0180108","article-title":"Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis","volume":"12","author":"R Song","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"pone.0286097.ref032","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1111\/bcp.14805","article-title":"Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations","volume":"87","author":"DR Morales","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"pone.0286097.ref033","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-45-6-1187","article-title":"The placental transfer of propylthiouracil, methimazole and carbimazole","volume":"45","author":"B Marchant","year":"1977","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"pone.0286097.ref034","article-title":"Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis","author":"M Agrawal","year":"2021","journal-title":"Clinical endocrinology"},{"issue":"16","key":"pone.0286097.ref035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10163742","article-title":"Hyperthyroidism in Pregnancy: The Delicate Balance between Too Much or Too Little Antithyroid Drug","volume":"10","author":"ML Gheorghiu","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"pone.0286097.ref036","doi-asserted-by":"crossref","first-page":"453","DOI":"10.6061\/clinics\/2015(06)12","article-title":"Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis","volume":"70","author":"X Li","year":"2015","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"11","key":"pone.0286097.ref037","first-page":"1077","article-title":"The safety of methimazole and propylthiouracil in pregnancy: a systematic review","volume":"34","author":"R Hackmon","year":"2012","journal-title":"Journal of obstetrics and gynaecology Canada: JOGC = Journal d\u2019obstetrique et gynecologie du Canada: JOGC"},{"issue":"12","key":"pone.0286097.ref038","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1210\/clinem\/dgaa646","article-title":"Management of Graves Thyroidal and Extrathyroidal Disease: An Update","volume":"105","author":"GJ Kahaly","year":"2020","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"5","key":"pone.0286097.ref039","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MED.0b013e3283565b49","article-title":"The propylthiouracil dilemma","volume":"19","author":"D Glinoer","year":"2012","journal-title":"Current opinion in endocrinology, diabetes, and obesity"},{"issue":"10","key":"pone.0286097.ref040","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1517\/14740338.2014.953796","article-title":"Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity","volume":"13","author":"A Akmal","year":"2014","journal-title":"Expert opinion on drug safety"},{"issue":"7","key":"pone.0286097.ref041","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The Role of Propylthiouracil in the Management of Graves\u2019 Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration","volume":"19","author":"RS Bahn","year":"2009","journal-title":"Thyroid: official journal of the American Thyroid Association"},{"issue":"3","key":"pone.0286097.ref042","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","author":"MT Wang","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"pone.0286097.ref043","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40618-019-01148-w","article-title":"Treatment of Graves\u2019 hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy","volume":"43","author":"M Tonacchera","year":"2020","journal-title":"Journal of endocrinological investigation"},{"issue":"19","key":"pone.0286097.ref044","article-title":"Pregnancy Outcomes among Women with Graves\u2019 Hyperthyroidism: A Retrospective Cohort Study","volume":"10","author":"P Harn AM","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"pone.0286097.ref045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/rmb2.12325","article-title":"Risk factors of subclinical hypothyroidism and the potential contribution to miscarriage: A review","volume":"19","author":"S So","year":"2020","journal-title":"Reproductive medicine and biology"},{"key":"pone.0286097.ref046","first-page":"909","article-title":"Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience","author":"R Assi","year":"2020","journal-title":"Leukemia & Lymphoma"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:23:51Z","timestamp":1684502631000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0286097"}},"subtitle":[],"editor":[{"given":"Vijayalakshmi","family":"Kakulapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0286097","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}